Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2022
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC ConsortiumAngie Mae Rodday, Susan K Parsons, Jenica N Upshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
JCO Oncology Practice|February 20, 2025
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative StudyJeanne M Ferrante, Myneka Macenat, Jenna Howard, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2013
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern eraA M Evens, S Choquet, A R Kroll-Desrosiers, et al.
Blood Neoplasia|July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During PregnancyDaan Dierickx, Joosje H Heimovaara, Mar Bellido, et al.
Blood Advances|January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimenReem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2022
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC ConsortiumAngie Mae Rodday, Susan K Parsons, Jenica N Upshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
JCO Oncology Practice|February 20, 2025
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative StudyJeanne M Ferrante, Myneka Macenat, Jenna Howard, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2013
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern eraA M Evens, S Choquet, A R Kroll-Desrosiers, et al.
Blood Neoplasia|July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During PregnancyDaan Dierickx, Joosje H Heimovaara, Mar Bellido, et al.
Blood Advances|January 18, 2024
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimenReem Karmali, Carlos Galvez, Mehdi Hamadani, et al.
Pageof 26